StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.18−0.46 (-3.95%)

Close on Nov 19, 2026Market cap $1.45BP/E –Yield –

Mesoblast free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -$44.66M.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$44.66M–
FY2025Jun 30, 2025-$50.63M–
FY2024Jun 30, 2024-$48.73M–
FY2023Jun 30, 2023-$63.53M–

More Mesoblast figures

See a number that looks wrong?